Company intelligence / Profile preview

enVVeno Medical

Irvine, California, United Statesmarketscreener.com ↗

Ownership: Public · NVNO
Employees: ~37
Development stage: Phase 3

Overview

The company’s lead product, VenoValve®, has completed patient enrollment in its U.S. pivotal SAVVE® trial for severe deep venous CVI and has reported positive topline efficacy data at six months, showing significant clinical improvement and meaningful benefit. The device awaits FDA premarket approval submission. A second program, enVVe™, a non-surgical transcatheter valve system, is preparing for first-in-human trials. Both products are investigational and not yet approved or cleared for any indication.

Therapeutic areas: Cardiovascular
Modalities: Bioprosthetic tissue-based medical devices
Industry: Implantable Medical Devices

Drug pipeline

2 assets

VenoValve

Phase 3

Indications: Chronic Venous Insufficiency

1 more asset in the full pipeline.

Request access →

Financials

Market cap: $183.5K
Total revenue: $0
Enterprise value: $-20.8M

Beyond the preview

Go deeper on enVVeno Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on enVVeno Medical.

Explore the full profile